Skip to main content
OpenTrials

Clinical trial condition

Vision Disorders

Explore clinical trials studying Vision Disorders. Study availability and eligibility vary by location and protocol.

255 public trials 39 recruiting studies
Refine in advanced search Browse all conditions

Vision Disorders trial results

Completed

Advancing Understanding of Transportation Options

NCT04141891

Conditions
Acute Coronary Syndrome, Aortic Stenosis, Subvalvular, Aortic Valve Disease, +122 more
Locations
  • University of California, San Diego La Jolla, California, United States
  • CU Anschutz Medical Center Aurora, Colorado, United States
  • Indiana University Indianapolis, Indiana, United States
View Trial Details
Completed

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

NCT04047472

Conditions
Eye Diseases, Macular Degeneration, Neovascular Age-related Macular Degeneration, +9 more
Locations
  • Novartis Investigative Site Beijing, Beijing Municipality, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Shantou, Guangdong, China
View all 30 locations
View Trial Details
Completed

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

NCT04264819

Conditions
Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +22 more
Locations
  • Novartis Investigative Site Nice, Cedex1, France
  • Novartis Investigative Site Rennes, FRA, France
  • Novartis Investigative Site Saint-Cyr-sur-Loire, Indre Et Loire, France
  • Novartis Investigative Site Lyon, Rhone, France
View all 51 locations
View Trial Details
Completed

An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study

NCT04597632

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +16 more
Locations
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Fort Lauderdale, Florida, United States
  • Novartis Investigative Site Indianapolis, Indiana, United States
  • Novartis Investigative Site Minneapolis, Minnesota, United States
View all 60 locations
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

NCT04005352

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +17 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Loma Linda, California, United States
  • Novartis Investigative Site Riverside, California, United States
View all 118 locations
View Trial Details

Related conditions